NNZ-2566: A Gly–Pro–Glu analogue with neuroprotective efficacy in a rat model of acute focal stroke

@article{Bickerdike2009NNZ2566AG,
  title={NNZ-2566: A Gly–Pro–Glu analogue with neuroprotective efficacy in a rat model of acute focal stroke},
  author={M. J. Bickerdike and G. Thomas and D. C. Batchelor and E. Sirimanne and P. Gluckman},
  journal={Journal of the Neurological Sciences},
  year={2009},
  volume={278},
  pages={85-90}
}
  • M. J. Bickerdike, G. Thomas, +2 authors P. Gluckman
  • Published 2009
  • Medicine
  • Journal of the Neurological Sciences
  • The N-terminal cleavage product of human insulin-like growth factor-1 (IGF-1) in the brain is the tripeptide molecule Glypromate (Gly-Pro-Glu). Glypromate has demonstrated neuroprotective effects in numerous in vitro and in vivo models of brain injury and is in clinical trials for the prevention of cognitive impairment following cardiac surgery. NNZ-2566 is a structural analogue of Glypromate, resulting from alpha-methylation of the proline moiety, which has improved the elimination half-life… CONTINUE READING
    23 Citations
    GPE and GPE analogues as promising neuroprotective agents.
    • 24
    The role for IGF-1-derived small neuropeptides as a therapeutic target for neurological disorders
    • 20
    NNZ-2566, a Glypromate Analog, Attenuates Brain Ischemia-Induced Non-Convulsive Seizures in Rats
    • 21
    • Highly Influenced
    • PDF
    NNZ-2566, a Novel Analog of (1–3) IGF-1, as a Potential Therapeutic Agent for Fragile X Syndrome
    • 40
    • PDF
    Insulin‐Like Growth Factor ‐1 (IGF‐1) Derived Neuropeptides, a Novel Strategy for the Development of Pharmaceuticals for Managing Ischemic Brain Injury
    • J. Guan
    • Medicine
    • CNS neuroscience & therapeutics
    • 2011
    • 12
    Population pharmacokinetics of NNZ‐2566 in healthy subjects
    • 2
    • Highly Influenced
    • PDF

    References

    SHOWING 1-10 OF 36 REFERENCES
    Neuroprotective effects of Gly-Pro-Glu, the N-terminal tripeptide of IGF-1, in the hippocampus in vitro.
    • 50
    Pharmacokinetics of glycine-proline-glutamate, the N-terminal tripeptide of insulin-like growth factor-1, in rats.
    • 32
    Identification of Gly-Pro-Glu (GPE), the aminoterminal tripeptide of insulin-like growth factor 1 which is truncated in brain, as a novel neuroactive peptide.
    • 94